Compare $TCRX vs $VICP | Chartloom

Compare

$TCRX vs $VICP

TScan Therapeutics Inc · Vicapsys Life Sciences Inc

TCRX

TScan Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Compare $TCRX vs $VICP

Comparing TScan Therapeutics Inc and Vicapsys Life Sciences Inc

TCRXTScan Therapeutics Inc

VICPVicapsys Life Sciences Inc

TCRXTScan Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.85x

Rev growth (TTM)

2.2%

YTD performance

-76.7%

52W performance

-88.0%

FCF yield

-761.5%

VICPVicapsys Life Sciences Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-63.3%

52W performance

-68.9%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TCRX

VICP

Detailed metrics comparison

TCRX

TScan Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

TCRX$16M

VICP$18M

Enterprise Value

TCRX$-52M

VICP$18M

Price

TCRX$0.24

VICP$0.55

P/E Ratio

TCRXN/A

VICPN/A

P/S Ratio

TCRX2.19x

VICP0.00x

EV/Sales

TCRX-7.29x

VICP0.00x

EV/EBITDA

TCRX0.00x

VICP0.00x

P/B Ratio

TCRX0.31x

VICPN/A

P/FCF Ratio

TCRXN/A

VICPN/A

EV/FCF

TCRX0.44x

VICP0.00x

PEG Ratio

TCRXN/A

VICPN/A

Forward P/E (NTM)

TCRXN/A

VICPN/A

Forward P/S (NTM)

TCRX8.85x

VICPN/A

Revenue (TTM)

TCRX$7M

VICP$0

Revenue Growth (YoY)

TCRX2.2%

VICPN/A

Forward Rev Growth

TCRX42.6%

VICP0.0%

Gross Margin (TTM)

TCRX0.0%

VICP0.0%

Operating Margin (TTM)

TCRX0.0%

VICP0.0%

EBITDA Margin (TTM)

TCRX-1626.5%

VICP0.0%

Net Margin (TTM)

TCRX-1655.4%

VICP0.0%

FCF Margin (TTM)

TCRX-1665.6%

VICPN/A

Net Income (TTM)

TCRX$-118M

VICPN/A

FCF (TTM)

TCRX$-118M

VICP$0

EPS (TTM)

TCRX-$0.91

VICP$0.00

ROE (TTM)

TCRX-10872.0%

VICP0.0%

ROA (TTM)

TCRX-5447.0%

VICP0.0%

ROIC (TTM)

TCRX-8356.0%

VICP0.0%

Cash

TCRX$100M

VICP$90K

Debt

TCRX$33M

VICP$579K

Net Cash/Debt

TCRX$67M

VICP$-489K

Current Ratio (TTM)

TCRX3.37x

VICP0.03x

Quick Ratio (TTM)

TCRX3.23x

VICP0.03x

Debt/Equity (TTM)

TCRX0.47x

VICP0.00x

Debt/Assets (TTM)

TCRX0.0%

VICP0.0%

Interest Coverage (TTM)

TCRXN/A

VICPN/A

Net Debt/EBITDA (TTM)

TCRX0.00x

VICP0.00x

Beta

TCRX1.19

VICP-3.98

52W Performance

TCRX-88.0%

VICP-68.9%

YTD Performance

TCRX-76.7%

VICP-63.3%

% from 52W High

TCRX-90.7%

VICP-68.9%

% from 52W Low

TCRX6.1%

VICP399.9%

Asset Turnover (TTM)

TCRX0.03x

VICP0.00x

FCF Yield (TTM)

TCRX-761.5%

VICP0.0%

Earnings Yield (TTM)

TCRX-756.8%

VICP0.0%

Dividend Yield (TTM)

TCRXN/A

VICPN/A

Rule of 40

TCRX-1,663.4

VICP0.0

EV/GP/RG

TCRXN/A

VICPN/A

Ticker research

View TCRX research View VICP research

Metric	TCRX TScan Therapeutics Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$16M	$18M
Enterprise Value	$-52M	$18M
Price	$0.24	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	2.19x	0.00x
EV/Sales	-7.29x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.31x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	0.44x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	8.85x	N/A
Revenue & Growth
Revenue (TTM)	$7M	$0
Revenue Growth (YoY)	2.2%	N/A
Forward Rev Growth	42.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1626.5%	0.0%
Net Margin (TTM)	-1655.4%	0.0%
FCF Margin (TTM)	-1665.6%	N/A
Net Income (TTM)	$-118M	N/A
FCF (TTM)	$-118M	$0
EPS (TTM)	-$0.91	$0.00
ROE (TTM)	-10872.0%	0.0%
ROA (TTM)	-5447.0%	0.0%
ROIC (TTM)	-8356.0%	0.0%
Financial Health
Cash	$100M	$90K
Debt	$33M	$579K
Net Cash/Debt	$67M	$-489K
Current Ratio (TTM)	3.37x	0.03x
Quick Ratio (TTM)	3.23x	0.03x
Debt/Equity (TTM)	0.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.19	-3.98
52W Performance	-88.0%	-68.9%
YTD Performance	-76.7%	-63.3%
% from 52W High	-90.7%	-68.9%
% from 52W Low	6.1%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.00x
FCF Yield (TTM)	-761.5%	0.0%
Earnings Yield (TTM)	-756.8%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,663.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View TCRX research	View VICP research

Valuation

P/S Ratio

VICP

0.00x

TCRX

2.19x

EV/FCF

VICP

0.00x

TCRX

0.44x

Growth & revenue

Revenue Growth TTM

TCRX

2.2%

Forward Revenue Growth

TCRX

42.6%

VICP

0.0%

Profitability & performance

Gross Margin

TCRX

0.0%

VICP

0.0%

ROE

VICP

0.0%

TCRX

-10872.0%

FCF Yield %

VICP

0.0%

TCRX

-761.5%

52-Week Performance

VICP

-68.9%

TCRX

-88.0%

Detailed metrics comparison

TCRX

TScan Therapeutics Inc

VICP

Vicapsys Life Sciences Inc

Market Cap

TCRX$16M

VICP$18M

Enterprise Value

TCRX$-52M

VICP$18M

Price

TCRX$0.24

VICP$0.55

P/E Ratio

TCRXN/A

VICPN/A

P/S Ratio

TCRX2.19x

VICP0.00x

EV/Sales

TCRX-7.29x

VICP0.00x

EV/EBITDA

TCRX0.00x

VICP0.00x

P/B Ratio

TCRX0.31x

VICPN/A

P/FCF Ratio

TCRXN/A

VICPN/A

EV/FCF

TCRX0.44x

VICP0.00x

PEG Ratio

TCRXN/A

VICPN/A

Forward P/E (NTM)

TCRXN/A

VICPN/A

Forward P/S (NTM)

TCRX8.85x

VICPN/A

Revenue (TTM)

TCRX$7M

VICP$0

Revenue Growth (YoY)

TCRX2.2%

VICPN/A

Forward Rev Growth

TCRX42.6%

VICP0.0%

Gross Margin (TTM)

TCRX0.0%

VICP0.0%

Operating Margin (TTM)

TCRX0.0%

VICP0.0%

EBITDA Margin (TTM)

TCRX-1626.5%

VICP0.0%

Net Margin (TTM)

TCRX-1655.4%

VICP0.0%

FCF Margin (TTM)

TCRX-1665.6%

VICPN/A

Net Income (TTM)

TCRX$-118M

VICPN/A

FCF (TTM)

TCRX$-118M

VICP$0

EPS (TTM)

TCRX-$0.91

VICP$0.00

ROE (TTM)

TCRX-10872.0%

VICP0.0%

ROA (TTM)

TCRX-5447.0%

VICP0.0%

ROIC (TTM)

TCRX-8356.0%

VICP0.0%

Cash

TCRX$100M

VICP$90K

Debt

TCRX$33M

VICP$579K

Net Cash/Debt

TCRX$67M

VICP$-489K

Current Ratio (TTM)

TCRX3.37x

VICP0.03x

Quick Ratio (TTM)

TCRX3.23x

VICP0.03x

Debt/Equity (TTM)

TCRX0.47x

VICP0.00x

Debt/Assets (TTM)

TCRX0.0%

VICP0.0%

Interest Coverage (TTM)

TCRXN/A

VICPN/A

Net Debt/EBITDA (TTM)

TCRX0.00x

VICP0.00x

Beta

TCRX1.19

VICP-3.98

52W Performance

TCRX-88.0%

VICP-68.9%

YTD Performance

TCRX-76.7%

VICP-63.3%

% from 52W High

TCRX-90.7%

VICP-68.9%

% from 52W Low

TCRX6.1%

VICP399.9%

Asset Turnover (TTM)

TCRX0.03x

VICP0.00x

FCF Yield (TTM)

TCRX-761.5%

VICP0.0%

Earnings Yield (TTM)

TCRX-756.8%

VICP0.0%

Dividend Yield (TTM)

TCRXN/A

VICPN/A

Rule of 40

TCRX-1,663.4

VICP0.0

EV/GP/RG

TCRXN/A

VICPN/A

Ticker research

View TCRX research View VICP research

Metric	TCRX TScan Therapeutics Inc	VICP Vicapsys Life Sciences Inc
Market & Valuation
Market Cap	$16M	$18M
Enterprise Value	$-52M	$18M
Price	$0.24	$0.55
P/E Ratio	N/A	N/A
P/S Ratio	2.19x	0.00x
EV/Sales	-7.29x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.31x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	0.44x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	8.85x	N/A
Revenue & Growth
Revenue (TTM)	$7M	$0
Revenue Growth (YoY)	2.2%	N/A
Forward Rev Growth	42.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1626.5%	0.0%
Net Margin (TTM)	-1655.4%	0.0%
FCF Margin (TTM)	-1665.6%	N/A
Net Income (TTM)	$-118M	N/A
FCF (TTM)	$-118M	$0
EPS (TTM)	-$0.91	$0.00
ROE (TTM)	-10872.0%	0.0%
ROA (TTM)	-5447.0%	0.0%
ROIC (TTM)	-8356.0%	0.0%
Financial Health
Cash	$100M	$90K
Debt	$33M	$579K
Net Cash/Debt	$67M	$-489K
Current Ratio (TTM)	3.37x	0.03x
Quick Ratio (TTM)	3.23x	0.03x
Debt/Equity (TTM)	0.47x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.19	-3.98
52W Performance	-88.0%	-68.9%
YTD Performance	-76.7%	-63.3%
% from 52W High	-90.7%	-68.9%
% from 52W Low	6.1%	399.9%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.00x
FCF Yield (TTM)	-761.5%	0.0%
Earnings Yield (TTM)	-756.8%	0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,663.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View TCRX research	View VICP research